Theravance Biopharma Inc (TBPH) — Capital Reinvestment Ratio
Theravance Biopharma Inc (TBPH) has a Capital Reinvestment Ratio of 0.00x as of June 2025, meaning it reinvests 0% of its operating cash flow ($208.07 Million) in capital expenditures ($34.00K). See net asset quality index of Theravance Biopharma Inc to measure how much of total assets are equity-financed.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Theravance Biopharma Inc Capital Reinvestment Ratio (2025–2025)
This chart tracks Theravance Biopharma Inc's Capital Reinvestment Ratio across 1 annual periods. Check cash flow reinvestment rate of Theravance Biopharma Inc to assess the company's total reinvestment commitment from operating cash flow.
Annual Capital Reinvestment Ratio for Theravance Biopharma Inc (2025–2025)
Year-by-year Capital Reinvestment Ratio for Theravance Biopharma Inc from 2025 to 2025. For live market cap and broader valuation context, see how much is Theravance Biopharma Inc worth.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2025 | 0.00x | $238.54 Million | $42.00K | — |